CD8A and breast cancer: Furthermore, we demonstrated that monocyte-derived IFN-DC loaded with oxidized tumor cell lysate derived from both patient-derived metastatic cells and BC organoids can effectively elicit an anti-tumor Th1-skewed response and CD8+ cytotoxic activity.